Global NASH Therapeutic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
![](/report_cover/9988/global-nash-therapeutic-drugs-market-2021-by-company-regions-type-n-application-forecast-to-2026_en.gif)
According to our (Global Info Research) latest study, the global NASH Therapeutic Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the NASH Therapeutic Drugs industry chain, the market status of Hospital Pharmacy (Vitamin E and Pioglitazone, Ocaliva), Online Provider (Vitamin E and Pioglitazone, Ocaliva), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of NASH Therapeutic Drugs.
Regionally, the report analyzes the NASH Therapeutic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global NASH Therapeutic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the NASH Therapeutic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the NASH Therapeutic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vitamin E and Pioglitazone, Ocaliva).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the NASH Therapeutic Drugs market.
Regional Analysis: The report involves examining the NASH Therapeutic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the NASH Therapeutic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to NASH Therapeutic Drugs:
Company Analysis: Report covers individual NASH Therapeutic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards NASH Therapeutic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Online Provider).
Technology Analysis: Report covers specific technologies relevant to NASH Therapeutic Drugs. It assesses the current state, advancements, and potential future developments in NASH Therapeutic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the NASH Therapeutic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
NASH Therapeutic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe NASH Therapeutic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of NASH Therapeutic Drugs, with revenue, gross margin and global market share of NASH Therapeutic Drugs from 2019 to 2024.
Chapter 3, the NASH Therapeutic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and NASH Therapeutic Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of NASH Therapeutic Drugs.
Chapter 13, to describe NASH Therapeutic Drugs research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the NASH Therapeutic Drugs industry chain, the market status of Hospital Pharmacy (Vitamin E and Pioglitazone, Ocaliva), Online Provider (Vitamin E and Pioglitazone, Ocaliva), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of NASH Therapeutic Drugs.
Regionally, the report analyzes the NASH Therapeutic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global NASH Therapeutic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the NASH Therapeutic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the NASH Therapeutic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vitamin E and Pioglitazone, Ocaliva).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the NASH Therapeutic Drugs market.
Regional Analysis: The report involves examining the NASH Therapeutic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the NASH Therapeutic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to NASH Therapeutic Drugs:
Company Analysis: Report covers individual NASH Therapeutic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards NASH Therapeutic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Online Provider).
Technology Analysis: Report covers specific technologies relevant to NASH Therapeutic Drugs. It assesses the current state, advancements, and potential future developments in NASH Therapeutic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the NASH Therapeutic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
NASH Therapeutic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Vitamin E and Pioglitazone
- Ocaliva
- Elafibranor
- Selonsertib and Cenicriviroc
- Hospital Pharmacy
- Online Provider
- Retail Pharmacy
- Allergan Plc (Tobira)
- Bristol Myers Squibb
- Galmed Pharmaceuticals
- Genfit SA
- Gilead Sciences, Inc.
- Intercept Pharmaceuticals, Inc.
- Zydus Cadila
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe NASH Therapeutic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of NASH Therapeutic Drugs, with revenue, gross margin and global market share of NASH Therapeutic Drugs from 2019 to 2024.
Chapter 3, the NASH Therapeutic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and NASH Therapeutic Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of NASH Therapeutic Drugs.
Chapter 13, to describe NASH Therapeutic Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of NASH Therapeutic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of NASH Therapeutic Drugs by Type
1.3.1 Overview: Global NASH Therapeutic Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global NASH Therapeutic Drugs Consumption Value Market Share by Type in 2023
1.3.3 Vitamin E and Pioglitazone
1.3.4 Ocaliva
1.3.5 Elafibranor
1.3.6 Selonsertib and Cenicriviroc
1.4 Global NASH Therapeutic Drugs Market by Application
1.4.1 Overview: Global NASH Therapeutic Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacy
1.4.3 Online Provider
1.4.4 Retail Pharmacy
1.5 Global NASH Therapeutic Drugs Market Size & Forecast
1.6 Global NASH Therapeutic Drugs Market Size and Forecast by Region
1.6.1 Global NASH Therapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global NASH Therapeutic Drugs Market Size by Region, (2019-2030)
1.6.3 North America NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.6 South America NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Allergan Plc (Tobira)
2.1.1 Allergan Plc (Tobira) Details
2.1.2 Allergan Plc (Tobira) Major Business
2.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Product and Solutions
2.1.4 Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Allergan Plc (Tobira) Recent Developments and Future Plans
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Product and Solutions
2.2.4 Bristol Myers Squibb NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol Myers Squibb Recent Developments and Future Plans
2.3 Galmed Pharmaceuticals
2.3.1 Galmed Pharmaceuticals Details
2.3.2 Galmed Pharmaceuticals Major Business
2.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Product and Solutions
2.3.4 Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Galmed Pharmaceuticals Recent Developments and Future Plans
2.4 Genfit SA
2.4.1 Genfit SA Details
2.4.2 Genfit SA Major Business
2.4.3 Genfit SA NASH Therapeutic Drugs Product and Solutions
2.4.4 Genfit SA NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genfit SA Recent Developments and Future Plans
2.5 Gilead Sciences, Inc.
2.5.1 Gilead Sciences, Inc. Details
2.5.2 Gilead Sciences, Inc. Major Business
2.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Product and Solutions
2.5.4 Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.6 Intercept Pharmaceuticals, Inc.
2.6.1 Intercept Pharmaceuticals, Inc. Details
2.6.2 Intercept Pharmaceuticals, Inc. Major Business
2.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product and Solutions
2.6.4 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intercept Pharmaceuticals, Inc. Recent Developments and Future Plans
2.7 Zydus Cadila
2.7.1 Zydus Cadila Details
2.7.2 Zydus Cadila Major Business
2.7.3 Zydus Cadila NASH Therapeutic Drugs Product and Solutions
2.7.4 Zydus Cadila NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zydus Cadila Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global NASH Therapeutic Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of NASH Therapeutic Drugs by Company Revenue
3.2.2 Top 3 NASH Therapeutic Drugs Players Market Share in 2023
3.2.3 Top 6 NASH Therapeutic Drugs Players Market Share in 2023
3.3 NASH Therapeutic Drugs Market: Overall Company Footprint Analysis
3.3.1 NASH Therapeutic Drugs Market: Region Footprint
3.3.2 NASH Therapeutic Drugs Market: Company Product Type Footprint
3.3.3 NASH Therapeutic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global NASH Therapeutic Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global NASH Therapeutic Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global NASH Therapeutic Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
6.2 North America NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
6.3 North America NASH Therapeutic Drugs Market Size by Country
6.3.1 North America NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
6.3.2 United States NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
7.2 Europe NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
7.3 Europe NASH Therapeutic Drugs Market Size by Country
7.3.1 Europe NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.3 France NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Region
8.3.1 Asia-Pacific NASH Therapeutic Drugs Consumption Value by Region (2019-2030)
8.3.2 China NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.5 India NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
9.2 South America NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
9.3 South America NASH Therapeutic Drugs Market Size by Country
9.3.1 South America NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Country
10.3.1 Middle East & Africa NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 NASH Therapeutic Drugs Market Drivers
11.2 NASH Therapeutic Drugs Market Restraints
11.3 NASH Therapeutic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 NASH Therapeutic Drugs Industry Chain
12.2 NASH Therapeutic Drugs Upstream Analysis
12.3 NASH Therapeutic Drugs Midstream Analysis
12.4 NASH Therapeutic Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of NASH Therapeutic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of NASH Therapeutic Drugs by Type
1.3.1 Overview: Global NASH Therapeutic Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global NASH Therapeutic Drugs Consumption Value Market Share by Type in 2023
1.3.3 Vitamin E and Pioglitazone
1.3.4 Ocaliva
1.3.5 Elafibranor
1.3.6 Selonsertib and Cenicriviroc
1.4 Global NASH Therapeutic Drugs Market by Application
1.4.1 Overview: Global NASH Therapeutic Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacy
1.4.3 Online Provider
1.4.4 Retail Pharmacy
1.5 Global NASH Therapeutic Drugs Market Size & Forecast
1.6 Global NASH Therapeutic Drugs Market Size and Forecast by Region
1.6.1 Global NASH Therapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global NASH Therapeutic Drugs Market Size by Region, (2019-2030)
1.6.3 North America NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.6 South America NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa NASH Therapeutic Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Allergan Plc (Tobira)
2.1.1 Allergan Plc (Tobira) Details
2.1.2 Allergan Plc (Tobira) Major Business
2.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Product and Solutions
2.1.4 Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Allergan Plc (Tobira) Recent Developments and Future Plans
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Product and Solutions
2.2.4 Bristol Myers Squibb NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol Myers Squibb Recent Developments and Future Plans
2.3 Galmed Pharmaceuticals
2.3.1 Galmed Pharmaceuticals Details
2.3.2 Galmed Pharmaceuticals Major Business
2.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Product and Solutions
2.3.4 Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Galmed Pharmaceuticals Recent Developments and Future Plans
2.4 Genfit SA
2.4.1 Genfit SA Details
2.4.2 Genfit SA Major Business
2.4.3 Genfit SA NASH Therapeutic Drugs Product and Solutions
2.4.4 Genfit SA NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Genfit SA Recent Developments and Future Plans
2.5 Gilead Sciences, Inc.
2.5.1 Gilead Sciences, Inc. Details
2.5.2 Gilead Sciences, Inc. Major Business
2.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Product and Solutions
2.5.4 Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.6 Intercept Pharmaceuticals, Inc.
2.6.1 Intercept Pharmaceuticals, Inc. Details
2.6.2 Intercept Pharmaceuticals, Inc. Major Business
2.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product and Solutions
2.6.4 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intercept Pharmaceuticals, Inc. Recent Developments and Future Plans
2.7 Zydus Cadila
2.7.1 Zydus Cadila Details
2.7.2 Zydus Cadila Major Business
2.7.3 Zydus Cadila NASH Therapeutic Drugs Product and Solutions
2.7.4 Zydus Cadila NASH Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zydus Cadila Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global NASH Therapeutic Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of NASH Therapeutic Drugs by Company Revenue
3.2.2 Top 3 NASH Therapeutic Drugs Players Market Share in 2023
3.2.3 Top 6 NASH Therapeutic Drugs Players Market Share in 2023
3.3 NASH Therapeutic Drugs Market: Overall Company Footprint Analysis
3.3.1 NASH Therapeutic Drugs Market: Region Footprint
3.3.2 NASH Therapeutic Drugs Market: Company Product Type Footprint
3.3.3 NASH Therapeutic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global NASH Therapeutic Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global NASH Therapeutic Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global NASH Therapeutic Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
6.2 North America NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
6.3 North America NASH Therapeutic Drugs Market Size by Country
6.3.1 North America NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
6.3.2 United States NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
7.2 Europe NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
7.3 Europe NASH Therapeutic Drugs Market Size by Country
7.3.1 Europe NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.3 France NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Region
8.3.1 Asia-Pacific NASH Therapeutic Drugs Consumption Value by Region (2019-2030)
8.3.2 China NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.5 India NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
9.2 South America NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
9.3 South America NASH Therapeutic Drugs Market Size by Country
9.3.1 South America NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa NASH Therapeutic Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa NASH Therapeutic Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Country
10.3.1 Middle East & Africa NASH Therapeutic Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE NASH Therapeutic Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 NASH Therapeutic Drugs Market Drivers
11.2 NASH Therapeutic Drugs Market Restraints
11.3 NASH Therapeutic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 NASH Therapeutic Drugs Industry Chain
12.2 NASH Therapeutic Drugs Upstream Analysis
12.3 NASH Therapeutic Drugs Midstream Analysis
12.4 NASH Therapeutic Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global NASH Therapeutic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global NASH Therapeutic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global NASH Therapeutic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global NASH Therapeutic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Allergan Plc (Tobira) Company Information, Head Office, and Major Competitors
Table 6. Allergan Plc (Tobira) Major Business
Table 7. Allergan Plc (Tobira) NASH Therapeutic Drugs Product and Solutions
Table 8. Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Allergan Plc (Tobira) Recent Developments and Future Plans
Table 10. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 11. Bristol Myers Squibb Major Business
Table 12. Bristol Myers Squibb NASH Therapeutic Drugs Product and Solutions
Table 13. Bristol Myers Squibb NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bristol Myers Squibb Recent Developments and Future Plans
Table 15. Galmed Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Galmed Pharmaceuticals Major Business
Table 17. Galmed Pharmaceuticals NASH Therapeutic Drugs Product and Solutions
Table 18. Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Galmed Pharmaceuticals Recent Developments and Future Plans
Table 20. Genfit SA Company Information, Head Office, and Major Competitors
Table 21. Genfit SA Major Business
Table 22. Genfit SA NASH Therapeutic Drugs Product and Solutions
Table 23. Genfit SA NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Genfit SA Recent Developments and Future Plans
Table 25. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
Table 26. Gilead Sciences, Inc. Major Business
Table 27. Gilead Sciences, Inc. NASH Therapeutic Drugs Product and Solutions
Table 28. Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Gilead Sciences, Inc. Recent Developments and Future Plans
Table 30. Intercept Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 31. Intercept Pharmaceuticals, Inc. Major Business
Table 32. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product and Solutions
Table 33. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Intercept Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 35. Zydus Cadila Company Information, Head Office, and Major Competitors
Table 36. Zydus Cadila Major Business
Table 37. Zydus Cadila NASH Therapeutic Drugs Product and Solutions
Table 38. Zydus Cadila NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Zydus Cadila Recent Developments and Future Plans
Table 40. Global NASH Therapeutic Drugs Revenue (USD Million) by Players (2019-2024)
Table 41. Global NASH Therapeutic Drugs Revenue Share by Players (2019-2024)
Table 42. Breakdown of NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in NASH Therapeutic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 44. Head Office of Key NASH Therapeutic Drugs Players
Table 45. NASH Therapeutic Drugs Market: Company Product Type Footprint
Table 46. NASH Therapeutic Drugs Market: Company Product Application Footprint
Table 47. NASH Therapeutic Drugs New Market Entrants and Barriers to Market Entry
Table 48. NASH Therapeutic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global NASH Therapeutic Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 50. Global NASH Therapeutic Drugs Consumption Value Share by Type (2019-2024)
Table 51. Global NASH Therapeutic Drugs Consumption Value Forecast by Type (2025-2030)
Table 52. Global NASH Therapeutic Drugs Consumption Value by Application (2019-2024)
Table 53. Global NASH Therapeutic Drugs Consumption Value Forecast by Application (2025-2030)
Table 54. North America NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 55. North America NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 56. North America NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 57. North America NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 58. North America NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 59. North America NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 60. Europe NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Europe NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Europe NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 63. Europe NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 64. Europe NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 67. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 68. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 69. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 70. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 72. South America NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 73. South America NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 74. South America NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 75. South America NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 76. South America NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 77. South America NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 79. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 80. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 81. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 82. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 83. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 84. NASH Therapeutic Drugs Raw Material
Table 85. Key Suppliers of NASH Therapeutic Drugs Raw Materials
Table 1. Global NASH Therapeutic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global NASH Therapeutic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global NASH Therapeutic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global NASH Therapeutic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Allergan Plc (Tobira) Company Information, Head Office, and Major Competitors
Table 6. Allergan Plc (Tobira) Major Business
Table 7. Allergan Plc (Tobira) NASH Therapeutic Drugs Product and Solutions
Table 8. Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Allergan Plc (Tobira) Recent Developments and Future Plans
Table 10. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 11. Bristol Myers Squibb Major Business
Table 12. Bristol Myers Squibb NASH Therapeutic Drugs Product and Solutions
Table 13. Bristol Myers Squibb NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bristol Myers Squibb Recent Developments and Future Plans
Table 15. Galmed Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 16. Galmed Pharmaceuticals Major Business
Table 17. Galmed Pharmaceuticals NASH Therapeutic Drugs Product and Solutions
Table 18. Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Galmed Pharmaceuticals Recent Developments and Future Plans
Table 20. Genfit SA Company Information, Head Office, and Major Competitors
Table 21. Genfit SA Major Business
Table 22. Genfit SA NASH Therapeutic Drugs Product and Solutions
Table 23. Genfit SA NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Genfit SA Recent Developments and Future Plans
Table 25. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
Table 26. Gilead Sciences, Inc. Major Business
Table 27. Gilead Sciences, Inc. NASH Therapeutic Drugs Product and Solutions
Table 28. Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Gilead Sciences, Inc. Recent Developments and Future Plans
Table 30. Intercept Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 31. Intercept Pharmaceuticals, Inc. Major Business
Table 32. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product and Solutions
Table 33. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Intercept Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 35. Zydus Cadila Company Information, Head Office, and Major Competitors
Table 36. Zydus Cadila Major Business
Table 37. Zydus Cadila NASH Therapeutic Drugs Product and Solutions
Table 38. Zydus Cadila NASH Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Zydus Cadila Recent Developments and Future Plans
Table 40. Global NASH Therapeutic Drugs Revenue (USD Million) by Players (2019-2024)
Table 41. Global NASH Therapeutic Drugs Revenue Share by Players (2019-2024)
Table 42. Breakdown of NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in NASH Therapeutic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 44. Head Office of Key NASH Therapeutic Drugs Players
Table 45. NASH Therapeutic Drugs Market: Company Product Type Footprint
Table 46. NASH Therapeutic Drugs Market: Company Product Application Footprint
Table 47. NASH Therapeutic Drugs New Market Entrants and Barriers to Market Entry
Table 48. NASH Therapeutic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global NASH Therapeutic Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 50. Global NASH Therapeutic Drugs Consumption Value Share by Type (2019-2024)
Table 51. Global NASH Therapeutic Drugs Consumption Value Forecast by Type (2025-2030)
Table 52. Global NASH Therapeutic Drugs Consumption Value by Application (2019-2024)
Table 53. Global NASH Therapeutic Drugs Consumption Value Forecast by Application (2025-2030)
Table 54. North America NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 55. North America NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 56. North America NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 57. North America NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 58. North America NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 59. North America NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 60. Europe NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Europe NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Europe NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 63. Europe NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 64. Europe NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 67. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 68. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 69. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 70. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Asia-Pacific NASH Therapeutic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 72. South America NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 73. South America NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 74. South America NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 75. South America NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 76. South America NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 77. South America NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 79. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 80. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 81. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 82. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 83. Middle East & Africa NASH Therapeutic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 84. NASH Therapeutic Drugs Raw Material
Table 85. Key Suppliers of NASH Therapeutic Drugs Raw Materials
LIST OF FIGURES
Figure 1. NASH Therapeutic Drugs Picture
Figure 2. Global NASH Therapeutic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global NASH Therapeutic Drugs Consumption Value Market Share by Type in 2023
Figure 4. Vitamin E and Pioglitazone
Figure 5. Ocaliva
Figure 6. Elafibranor
Figure 7. Selonsertib and Cenicriviroc
Figure 8. Global NASH Therapeutic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. NASH Therapeutic Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hospital Pharmacy Picture
Figure 11. Online Provider Picture
Figure 12. Retail Pharmacy Picture
Figure 13. Global NASH Therapeutic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global NASH Therapeutic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market NASH Therapeutic Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global NASH Therapeutic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. Global NASH Therapeutic Drugs Consumption Value Market Share by Region in 2023
Figure 18. North America NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South America NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Global NASH Therapeutic Drugs Revenue Share by Players in 2023
Figure 24. NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players NASH Therapeutic Drugs Market Share in 2023
Figure 26. Global Top 6 Players NASH Therapeutic Drugs Market Share in 2023
Figure 27. Global NASH Therapeutic Drugs Consumption Value Share by Type (2019-2024)
Figure 28. Global NASH Therapeutic Drugs Market Share Forecast by Type (2025-2030)
Figure 29. Global NASH Therapeutic Drugs Consumption Value Share by Application (2019-2024)
Figure 30. Global NASH Therapeutic Drugs Market Share Forecast by Application (2025-2030)
Figure 31. North America NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. North America NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. North America NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 34. United States NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. France NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific NASH Therapeutic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 48. China NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. India NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South America NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 55. South America NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 56. South America NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. NASH Therapeutic Drugs Market Drivers
Figure 66. NASH Therapeutic Drugs Market Restraints
Figure 67. NASH Therapeutic Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of NASH Therapeutic Drugs in 2023
Figure 70. Manufacturing Process Analysis of NASH Therapeutic Drugs
Figure 71. NASH Therapeutic Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. NASH Therapeutic Drugs Picture
Figure 2. Global NASH Therapeutic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global NASH Therapeutic Drugs Consumption Value Market Share by Type in 2023
Figure 4. Vitamin E and Pioglitazone
Figure 5. Ocaliva
Figure 6. Elafibranor
Figure 7. Selonsertib and Cenicriviroc
Figure 8. Global NASH Therapeutic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. NASH Therapeutic Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hospital Pharmacy Picture
Figure 11. Online Provider Picture
Figure 12. Retail Pharmacy Picture
Figure 13. Global NASH Therapeutic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global NASH Therapeutic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market NASH Therapeutic Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global NASH Therapeutic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 17. Global NASH Therapeutic Drugs Consumption Value Market Share by Region in 2023
Figure 18. North America NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. South America NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Global NASH Therapeutic Drugs Revenue Share by Players in 2023
Figure 24. NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players NASH Therapeutic Drugs Market Share in 2023
Figure 26. Global Top 6 Players NASH Therapeutic Drugs Market Share in 2023
Figure 27. Global NASH Therapeutic Drugs Consumption Value Share by Type (2019-2024)
Figure 28. Global NASH Therapeutic Drugs Market Share Forecast by Type (2025-2030)
Figure 29. Global NASH Therapeutic Drugs Consumption Value Share by Application (2019-2024)
Figure 30. Global NASH Therapeutic Drugs Market Share Forecast by Application (2025-2030)
Figure 31. North America NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. North America NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. North America NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 34. United States NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. France NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific NASH Therapeutic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 48. China NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. India NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South America NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 55. South America NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 56. South America NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa NASH Therapeutic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa NASH Therapeutic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa NASH Therapeutic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE NASH Therapeutic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 65. NASH Therapeutic Drugs Market Drivers
Figure 66. NASH Therapeutic Drugs Market Restraints
Figure 67. NASH Therapeutic Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of NASH Therapeutic Drugs in 2023
Figure 70. Manufacturing Process Analysis of NASH Therapeutic Drugs
Figure 71. NASH Therapeutic Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source